Wall Street Rallies Again as Russia Outmaneuvers Washington

Michael Teague  |

Tuesday Indices and Exchanges

●     Standard & Poor’s 500: +0.72 percent to 1,872.25

●     Dow Jones Industrial Average: +0.55 percent to 16,336.19

●     NASDAQ: +1.25 percent to 4,333.31

The US and its Western European allies were reduced to helpless spectators on the international stage on Tuesday, as Russia’s annexation of Crimea met with little more than rhetorical opposition. It was a positive for US equity markets, however, as stocks rallied across the board for a second straight day. Sanctions announced against a select number of wealthy Russian and Ukrainian individuals with strong ties to Moscow were laughed off with harsh sarcasm on instant messaging service Twitter (TWTR) by the Russian officials who were targeted. Investors weren’t terribly concerned about the global scale embarrassment of their leaders, however, and instead preoccupied themselves with moving money back into equities.

Our Top Stories

●     Karen Roche ofThe Gold Report  sits down for a fireside with Sprott Global CEO and junior mining potentate Rick Rule.

●     Perhaps nobody is sharp enough to follow Mr. Rule than Doug Casey himself, who has nine tips for speculative-minded readers.

●     In his weekly video missive, Benjamin Cox of junior mining research firm Oreninc succinctly debunks goldbug paranoia about the Federal Reserve.

●     Andy Waldock has some tips for Eurodollar traders.

●     Anthony Daher of Guild Investment Management sat down with Equities.com to talk bond strategy in a time of rising interest rates.

Trade Commission-FREE with Tradier Brokerage

●     Dennis Miller elucidates some of the important nuances between the unemployment rate and retirement for senior investors.

●     Senior Editor Joel Anderson explains that the final two weeks of open enrollment will be absolutely crucial for the future of the affordable care act.

●     The Life Sciences Report has an interview with respected biotech stock analyst Michael King on opportunities in the oncology space.

●     Senior Editor Jacob Harper explains why marijuana penny stocks are going up in smoke, and breaks down video-blogging platform Keek’s ($KEEK) decision to go public via a convoluted reverse takeover move by Canada’s Primary Petroleum corporation.


●     Tech giant Google (GOOG) added 1.60 percent during Tuesday’s session, with insiders relieving themselves of substantial chunks of the stock.

●     The Mining Report and Paul Adams talk Australian equity metals plays

●     The Energy Report and analyst Tom Varesh talk field services plays that are most likely to profit from midstream construction in Western Canada.

●     Drug-maker Geron Corporation (GERN) closed on gains and replacing some losses incurred from a sell-off in the previous week when the FDA put a hold on one of its cancer treatments.

●     Medical diagnostics firm BG Medicine (BGMD) closed the session on gains of 25 after gapping up at the opening bell, with plenty of evidence that investors are in for a short squeeze.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not necessarily represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer.


Symbol Last Price Change % Change